SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001619856-23-000002
Filing Date
2023-01-20
Accepted
2023-01-20 16:13:22
Documents
1
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167424918505378.html 4  
1 FORM 4 wf-form4_167424918505378.xml 4 3396
  Complete submission text file 0001619856-23-000002.txt   4795
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CARIBOU BIOSCIENCES, INC. 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
Rizvi Syed Ali-aamir (Reporting) CIK: 0001897621 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40631 | Film No.: 23541138